Holdco Nuvo Group D G Ltd Asset Turnover Ratio (NUVO), as of fourth quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Holdco Nuvo Group D g Ltd   (NASDAQ: NUVO)
 

Holdco Nuvo Group D G Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Holdco Nuvo Group D G Ltd asset turnover ratio, the ability of Holdco Nuvo Group D G Ltd 's assets to generate revenue in the fourth quarter 2023, increased sequentially to 0.01 in the fourth quarter (Dec 31 2023), yet the ratio remained below the average, as NUVO's position remain challenging.

Within sector 171 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2023 compared to the preceding quarter from 0 to 3754.

Asset Turnover Ratio Definition



NUVO Asset Turnover Ratio (Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter

Y / Y Asset Change 68.45 % - - - -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.01 - - - -
NUVO's Total Ranking # 3754 # 0 # 0 # 0 #
Seq. Asset Change 1034.91 % 0 % 0 % -85.16 % -
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 172
Healthcare Sector # 556
Overall Market # 3754

Asset Turnover Ratio Statistics
High Average Low
0.05 0.05 0.05
(Dec 31 2023)  







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
Catheter Precision Inc   0.01 $ 0.442  Millions$ 36.915  Millions
Clene Inc   0.01 $ 0.654  Millions$ 55.127  Millions
Bioxcel Therapeutics Inc   0.01 $ 1.380  Millions$ 123.588  Millions
Biorestorative Therapies Inc   0.01 $ 0.148  Millions$ 13.449  Millions
Shattuck Labs Inc   0.01 $ 1.657  Millions$ 155.742  Millions
Envoy Medical Inc   0.01 $ 0.316  Millions$ 30.113  Millions
Singular Genomics Systems Inc   0.01 $ 2.911  Millions$ 284.857  Millions
Fulcrum Therapeutics Inc   0.01 $ 2.805  Millions$ 289.506  Millions
Axim Biotechnologies Inc   0.01 $ 0.040  Millions$ 4.114  Millions
Vyne Therapeutics Inc   0.01 $ 0.424  Millions$ 44.294  Millions
Cytokinetics Incorporated  0.01 $ 7.530  Millions$ 808.661  Millions
Serina Therapeutics Inc   0.01 $ 0.104  Millions$ 11.497  Millions
Traws Pharma inc   0.01 $ 0.226  Millions$ 28.813  Millions
Fusion Pharmaceuticals Inc   0.01 $ 2.068  Millions$ 268.513  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 9.501  Millions
Pluri Inc   0.01 $ 0.357  Millions$ 50.594  Millions
Aim Immunotech Inc   0.01 $ 0.202  Millions$ 29.580  Millions
Oculis Holding Ag  0.01 $ 0.883  Millions$ 136.054  Millions
Inhibrx Biosciences Inc   0.01 $ 1.800  Millions$ 286.878  Millions
Evaxion A  0.01 $ 0.073  Millions$ 12.889  Millions
Century Therapeutics inc   0.01 $ 2.235  Millions$ 407.907  Millions
Lexicon Pharmaceuticals Inc 0.00 $ 1.205  Millions$ 246.337  Millions
Puretech Health Plc 0.00 $ 3.330  Millions$ 693.973  Millions
Ainos Inc 0.00 $ 0.122  Millions$ 34.114  Millions
Sera Prognostics Inc 0.00 $ 0.306  Millions$ 96.947  Millions
One World Products Inc 0.00 $ 0.008  Millions$ 2.462  Millions
Ovid Therapeutics Inc 0.00 $ 0.392  Millions$ 137.163  Millions
Rafael Holdings Inc 0.00 $ 0.275  Millions$ 97.379  Millions
Inmune Bio Inc 0.00 $ 0.155  Millions$ 65.849  Millions
China Health Industries Holdings Inc 0.00 $ 0.083  Millions$ 35.625  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.